Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenmei Yao

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Discovery|January 6, 2025
Integrated proteogenomic characterization of ampullary adenocarcinomaQiao Zhang, Xiaomeng Xu, Dongxian Jiang, et al.
Nature Communications|September 13, 2023
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situZhenmei Yao, Ning Xu, Guoguo Shang, et al.
Journal of Hematology & Oncology|June 6, 2022
Integrated proteogenomic characterization of urothelial carcinoma of the bladderNing Xu, Zhenmei Yao, Guoguo Shang, et al.
Molecular & Cellular Proteomics : MCP|April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancerNing Xu, Linhui Zhang, Zhenmei Yao, et al.
Nature Communications|February 15, 2024
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcomaShaoshuai Tang, Yunzhi Wang, Rongkui Luo, et al.
Nature Communications|April 15, 2025
Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancersZongfu Pan, Zhuo Tan, Ning Xu, et al.
Cell Reports. Medicine|August 26, 2023
Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinomaYuanyuan Qu, Zhenmei Yao, Ning Xu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Discovery|January 6, 2025
Integrated proteogenomic characterization of ampullary adenocarcinomaQiao Zhang, Xiaomeng Xu, Dongxian Jiang, et al.
Nature Communications|September 13, 2023
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situZhenmei Yao, Ning Xu, Guoguo Shang, et al.
Journal of Hematology & Oncology|June 6, 2022
Integrated proteogenomic characterization of urothelial carcinoma of the bladderNing Xu, Zhenmei Yao, Guoguo Shang, et al.
Molecular & Cellular Proteomics : MCP|April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancerNing Xu, Linhui Zhang, Zhenmei Yao, et al.
Nature Communications|February 15, 2024
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcomaShaoshuai Tang, Yunzhi Wang, Rongkui Luo, et al.
Nature Communications|April 15, 2025
Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancersZongfu Pan, Zhuo Tan, Ning Xu, et al.
Cell Reports. Medicine|August 26, 2023
Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinomaYuanyuan Qu, Zhenmei Yao, Ning Xu, et al.
Pageof 1